Fixed Low Dose Warfarin As Alternative Therapy To Prevent Thromboembolic Event In Atrial Fibrillation at Remote Area
Author : K. S. P. Adnyana, D. Y. Hermanto, Irnizarifka
Upload Date : 19-04-2018
Background: Preventing thromboembolic event in atrial fibrillation become a dilemma since the dissemination of health facilities in Indonesia was unequal. Not every hospital has an adequate resources to do INR examination, especially at remote area in Indonesia. In addition to patient compliance when multidrug was introduced, fixed-low-dose warfarin (FLDW) strategy using Indonesian 2-mg tablet was valuable to be studied, in the view of ischemic stroke prevention, major bleeding event, and cost efficiency compared to standard therapy.
Method: Descriptive study was carried out to identify ischemic stroke and bleeding event of FLDW in AF. This study used consecutive sampling from December 2016 to December 2017. All patients with atrial fibrillation using fixed low dose warfarin (2 mg) were included in this study. Patient who already using DAPT before and not adherence to the therapy are not include in this study. FLDW was introduced randomly once INR could not be checked again due to resources limitation.
Result: There were 172 patient with atrial fibrillation and after adapting to exclusion criteria, 51 patients were eligible to this study with mean age 57.49 years old. From demographic point of view, 29 patients (56.9%) are men. There are 16 patients (31.4%) with valvular atrial fibrillation, 3 patients (5.9%) with secondary atrial fibrillation because of thyroid dysfunction, and 32 patients (62.7%) with non-valvular atrial fibrillation. Ischemic stroke occur in 1 patient (2.0%) with mean of CHA2DS2-VASc score is 2.8. While, 4 patients (7.8%) have bleeding event consist of 3 events (5.9%) of gastrointestinal bleeding and 1 event (1.9%) of hemoptysis. The mean of HAS-BLED score is 2.6.
Conclusion: Fixed low dose warfarin can be used as alternative therapy in preventing thromboembolic event in atrial fibrillation at remote area whose don’t have INR examination. Risk of bleeding should be assessed carefully since fixed low dose warfarin has a significant bleeding episode. Futher study with larger sample size and prospective method is needed to represent the population
KEYWORDS : Atrial Fibrillation, thromboembolic event, fixed low dose warfarin
The Differences of Echocardiographic Features between Mitral Regurgitation Patients with Sinus Rhythm and Atrial Fibrillation (V. B Kusmanto, A. M. Soesanto, E. Rudiktyo, R. Ariani, B. R. M. A. S. Kuncoro)
Atrial Fibrillation is as a Predictor of in-Hospital Mortality of Acute Stroke Patients(N. H. Karunawan, R.T. Pinzon)
Difference in Prevalence of Atrial Fibrillation and Non Atrial Fibrillation in Non Valvular Heart Disease Stroke Patient (E. Pramana, K. Susila)
Cerebrovascular Thromboembolic Events in Periprocedural Bridging Therapy vs Uninterrupted Anticoagulation in Long-Term Anticoagulant User with Atrial Fibrillation: A Mini Systematic Review(Vidyawati, P. M. H Putri, T. Jatiman)
Converting Persistent Non-Valvular Atrial Fibrillation to Sinus Rhythm in Critical Stenosis of Left Circumflex (LCX) Artery: Is it Ischaemic-related?: A Case Report(F. Ratih, M.F. Rizky, K. Agoes)